These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11786894)

  • 1. The microarray way to tailored cancer treatment.
    Van 't Veer LJ; De Jong D
    Nat Med; 2002 Jan; 8(1):13-4. PubMed ID: 11786894
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
    Last K; Debarnardi S; Lister TA
    Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular diagnosis of malignant lymphomas].
    Holte H; Kvaløy S; Delabie J; Trøen G; Smeland EB
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2352-6. PubMed ID: 19935935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamentals in the pathological diagnosis of B-cell lymphoma, focusing on diffuse large B-cell lymphoma].
    Nakamine H
    Rinsho Ketsueki; 2007 Feb; 48(2):107-16. PubMed ID: 17370639
    [No Abstract]   [Full Text] [Related]  

  • 5. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
    Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma].
    Kobayashi T; Kim S; Zhang W; Yamaguchi M; Ueno S; Morikawa J; Shiku H
    Rinsho Ketsueki; 2003 Mar; 44(3):144-8. PubMed ID: 12722340
    [No Abstract]   [Full Text] [Related]  

  • 7. How diagnosis with microarrays can help cancer patients.
    Masters JR; Lakhani SR
    Nature; 2000 Apr; 404(6781):921. PubMed ID: 10801098
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
    Fu K; Iqbal J; Chan WC
    Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
    Shipp MA; Ross KN; Tamayo P; Weng AP; Kutok JL; Aguiar RC; Gaasenbeek M; Angelo M; Reich M; Pinkus GS; Ray TS; Koval MA; Last KW; Norton A; Lister TA; Mesirov J; Neuberg DS; Lander ES; Aster JC; Golub TR
    Nat Med; 2002 Jan; 8(1):68-74. PubMed ID: 11786909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
    Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
    Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA microarrays in lymphoid malignancies.
    Rosenwald A
    Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
    Zinzani PL; Dirnhofer S; Sabattini E; Alinari L; Piccaluga PP; Stefoni V; Tani M; Musuraca G; Marchi E; Falini B; Baccarani M; Pileri SA
    Haematologica; 2005 Mar; 90(3):341-7. PubMed ID: 15749666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
    Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
    Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach.
    Pileri SA; Ascani S; Zinzani PL; Gaidano G; Piccioli M; Rossi M; Piccaluga PP; Marafioti T; Pileri A; Pacini R; Falini B; Sabattini E
    Haematologica; 2002 Dec; 87(12):ECR40. PubMed ID: 12495911
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse large cell B cell lymphoma presenting as a unilateral eye mass.
    Hon C; Yau K; Shek TW; Au WY
    Am J Hematol; 2007 Apr; 82(4):325-6. PubMed ID: 17177187
    [No Abstract]   [Full Text] [Related]  

  • 17. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
    Segal MR
    Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma.
    Wu G; Keating A
    Cancer; 2006 Jan; 106(2):247-57. PubMed ID: 16342164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma.
    Barth TF; Barth CA; Kestler HA; Michl P; Weniger MA; Buchholz M; Möller P; Gress T
    J Pathol; 2007 Feb; 211(3):305-13. PubMed ID: 17152084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
    Valet GK; Hoeffkes HG
    Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.